Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
31.98
+2.60 (8.85%)
Apr 17, 2026, 4:08 PM HKT
| Market Cap | 4.36B |
| Revenue (ttm) | 18.49M +655.6% |
| Net Income | -145.79M |
| EPS | -1.24 |
| Shares Out | 136.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 108,900 |
| Average Volume | 187,110 |
| Open | 29.88 |
| Previous Close | 29.38 |
| Day's Range | 28.60 - 31.98 |
| 52-Week Range | 13.48 - 32.62 |
| Beta | 0.84 |
| RSI | 69.83 |
| Earnings Date | Mar 27, 2026 |